The expert network and electronic portal for children with respiratory and allergic symptoms: rationale and design

BMC Pediatrics

Cornelis K van der Ent¹  Bart E van Ewijk²  Walter A F Balemans³  Francine C van Erp¹  Kim Zomer-Kooijker¹ 

[1] Department of Pediatric Pulmonology and Allergology, Wilhelmina Children’s Hospital/University Medical Center Utrecht, PO Box 85090, 3508, Utrecht, AB, The Netherlands;Department of Pediatrics, Tergooi Hospital, Blaricum, The Netherlands;Department of Pediatrics, St. Antonius Hospital, Nieuwegein, The Netherlands

关键词: Children;    Follow up study;    Atopic diseases;    Respiratory complaints;    Asthma phenotypes;   

Others  :  1164280
DOI  :  10.1186/1471-2431-13-9

 received in 2012-04-16, accepted in 2013-01-09,  发布年份 2013

【 摘 要 】

Data on baseline characteristics of children with asthma to predict individual treatment responses are lacking. We aimed to set up a data-collection system which can easily fill this gap in clinical practice.

A web-based application was developed, named 'Portal for children with respiratory and allergic symptoms', hereafter called Electronic Portal (EP). It contains health- and disease-related questionnaires on respiratory- and allergic diseases. All patients, 1–18 years of age, with respiratory- and/or allergic complaints are invited to enter the EP before their first visit. By using the EP large amounts of data, gathered during routine patient care can be used for research purposes. This may help to further investigate the different treatment related asthma phenotypes and will be helpful to monitor risk factors for other atopic diseases and respiratory infections.

【 授权许可】

   
2013 Zomer-Kooijker et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Asher MI, Montefort S, Bjorksten B: Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006, 3689537:733-743.
• [2]Patel SP, Jarvelin MR, Little MP: Systematic review of worldwide variations of the prevalence of wheezing symptoms in children. Environ Health 2008, 7:57. BioMed Central Full Text
• [3]van Gent R, van Essen LE, Rovers MM, Kimpen JL, van der Ent CK, de Meer G: Quality of life in children with undiagnosed and diagnosed asthma. Eur J Pediatr 2007, 1668:843-848.
• [4]van Gent R, van Essen-Zandvliet EE, Klijn P, Brackel HJ, Kimpen JL, van Der Ent CK: Participation in daily life of children with asthma. J Asthma 2008, 459:807-813.
• [5]Rabe KF, Vermeire PA, Soriano JB, Maier WC: Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe AIRE study. Eur Respir J 2000, 165:802-807.
• [6]Fuhlbrigge AL, Guilbert T, Spahn J, Peden D, Davis K: The influence of variation in type and pattern of symptoms on assessment in pediatric asthma. Pediatrics 2006, 1182:619-625.
• [7]Knuffman JE, Sorkness CA, Lemanske RF Jr: Phenotypic predictors of long-term response to inhaled corticosteroid and leukotriene modifier therapies in pediatric asthma. J Allergy Clin Immunol 2009, 1232:411-416.
• [8]Bacharier LB, Guilbert TW, Zeiger RS: Patient characteristics associated with improved outcomes with use of an inhaled corticosteroid in preschool children at risk for asthma. J Allergy Clin Immunol 2009, 1235:1077-1082.
• [9]Martin RJ, Szefler SJ, King TS: The Predicting Response to Inhaled Corticosteroid Efficacy PRICE trial. J Allergy Clin Immunol 2007, 1191:73-80.
• [10]Zeiger RS, Szefler SJ, Phillips BR: Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma. J Allergy Clin Immunol 2006, 1171:45-52.
• [11]Lazarus SC, Chinchilli VM, Rollings NJ: Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med 2007, 1758:783-790.
• [12]De Blic J, Ogorodova L, Klink R: Salmeterol/fluticasone propionate vs. double dose fluticasone propionate on lung function and asthma control in children. Pediatr Allergy Immunol 2009, 208:763-771.
• [13]Gappa M, Zachgo W, Von BA, Kamin W, Stern-Strater C, Steinkamp G: Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial VIAPAED. Pediatr Pulmonol 2009, 4411:1132-1142.
• [14]Eisen M, Donald C, Ware JE: Conceptualization and measurment op health for children in the Health Insurance Study. Santa Monica CA: RAND Corporation; 1980. [Publication Series R-2313-HEW]
• [15]Post MW, Kuyvenhoven MM, Verheij MJ, de Melker RA, Hoes AW: The Dutch 'Rand General Health Rating Index for Children': a questionnaire measuring the general health status of children. Ned Tijdschr Geneeskd 1998, 14249:2680-2683.
• [16]Liu AH, Zeiger R, Sorkness C: Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol 2007, 1194:817-825.
• [17]Nathan RA, Sorkness CA, Kosinski M: Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004, 1131:59-65.
• [18]Cohen JL, Mann DM, Wisnivesky JP: Assessing the validity of self-reported medication adherence among inner-city asthmatic adults: the Medication Adherence Report Scale for Asthma. Ann Allergy Asthma Immunol 2009, 1034:325-331.
• [19]Raat H, Bueving HJ, de Jongste JC, Grol MH, Juniper EF, van der Wouden JC: Responsiveness, longitudinal- and cross-sectional construct validity of the Pediatric Asthma Quality of Life Questionnaire PAQLQ in Dutch children with asthma. Qual Life Res 2005, 141:265-272.
• [20]Brouilette R, Hanson D, David R: A diagnostic approach to suspected obstructive sleep apnea in children. J Pediatr 1984, 1051:10-14.
• [21]Kubba H, Swan IR, Gatehouse S: How appropriate is the OM6 as a discriminative instrument in children with otitis media? Arch Otolaryngol Head Neck Surg Jun 2004, 1306:705-709.
• [22]Bousquet J, Van CP, Khaltaev N: Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001, 1085:S147-S334.
• [23]Juniper EF, Howland WC, Roberts NB, Thompson AK, King DR: Measuring quality of life in children with rhinoconjunctivitis. J Allergy Clin Immunol 1998, 1012(Pt 1):163-170.
• [24]Juniper EF, Guyatt GH, Dolovich J: Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol 1994, 932:413-423.
• [25]Flokstra-de Blok BM, DunnGalvin A, Vlieg-Boerstra BJ: Development and validation of a self-administered Food Allergy Quality of Life Questionnaire for children. Clin Exp Allergy 2009, 391:127-137.
• [26]Flokstra-de Blok BM, DunnGalvin A, Vlieg-Boerstra BJ: Development and validation of the self-administered Food Allergy Quality of Life Questionnaire for adolescents. J Allergy Clin Immunol 2008, 1221:139-144.
• [27]Housman TS, Patel MJ, Camacho F, Feldman SR, Fleischer AB Jr, Balkrishnan R: Use of the Self-Administered Eczema Area and Severity Index by parent caregivers: results of a validation study. Br J Dermatol 2002, 1476:1192-1198.
• [28]van Velsen SG, Knol MJ, Haeck IM, Bruijnzeel-Koomen CA, Pasmans SG: The Self-administered Eczema Area and Severity Index in children with moderate to severe atopic dermatitis: better estimation of AD body surface area than severity. Pediatr Dermatol 2010, 275:470-475.
• [29]Lewis-Jones MS, Finlay AY, Dykes PJ: The Infants' Dermatitis Quality of Life Index. Br J Dermatol 2001, 1441:104-110.
• [30]Lewis-Jones MS, Finlay AY: The Children's Dermatology Life Quality Index CDLQI: initial validation and practical use. Br J Dermatol 1995, 1326:942-949.
• [31]Weiland SK, Björkstén B, Brunekreef B, Cookson WO, von Mutius E, Strachan DP, International Study of Asthma and Allergies in Childhood Phase II Study Group: Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): rationale and methods. Eur Respir J 2004, 24:406-412.
• [32]Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F: International Study of Asthma and Allergies in Childhood ISAAC: rationale and methods. Eur Respir J 1995, 83:483-491.
• [33]de Jongste JC, Vrijlandt EJLE: Astma bij kinderen. Samenvatting van de herziene richtlijnen van de Sectie Kinderlongziekten van de NVK. Amsterdam: Jurriaans Lindenbaum Grafimedia; 2007.
• [34]Standardized lung function testing. Official statement of the European Respiratory Society 1 Eur Respir J 1993, 16(Suppl 16):1-100.
• [35]Laszlo G: Standardisation of lung function testing: helpful guidance from the ATS/ERS Task Force. Thorax 2006, 619:744-746.
• [36]Byrne M, Walsh J, Murphy AW: Secondary prevention of coronary heart disease: patient beliefs and health-related behaviour. J Psychosom Res 2005, 585:403-415.
• [37]Brunekreef B, Smit J, De JJ, Neijens H: The prevention and incidence of asthma and mite allergy PIAMA birth cohort study: design and first results. Pediatr Allergy Immunol 2002, 15(13 Suppl):55-60.
• [38]Katier N, Uiterwaal CS, de Jong BM: The Wheezing Illnesses Study Leidsche Rijn WHISTLER: rationale and design. Eur J Epidemiol 2004, 199:895-903.
• [39]Kummeling I, Thijs C, Penders J: Etiology of atopy in infancy: the KOALA Birth Cohort Study. Pediatr Allergy Immunol 2005, 168:679-684.
• [40]Detmer D, Bloomrosen M, Raymond B, Tang P: Integrated personal health records: transformative tools for consumer-centric care. BMC Med Inform Decis Mak 2008, 8:45. BioMed Central Full Text
• [41]ICT gebruik van personen naar persoonskenmerkenhttp://statline.cbs.nl/StatWeb/publication/?DM=SLNL&PA=71102NED&D1=3&D2=0-5&D3=a&VW=T webcite
• [42]Houtkoop W: Basisvaardigheden in Nederland; De 'geletterdheid' van Nederland: economische, sociale en educatieve aspecten van de taal- en rekenvaardigheden van de Nederlandse beroepsbevolking. Amsterdam: Bureau Grafische Producties; 1999.